๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mycophenolate mofetil treatment for primary glomerular diseases

โœ Scribed by Choi, Michael J.; Eustace, Joseph A.; Gimenez, Luis F.; Atta, Mohamed G.; Scheel, Paul J.; Sothinathan, Renuka; Briggs, William A.

Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
246 KB
Volume
61
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Mycophenolate mofetil therapy for refrac
Mycophenolate mofetil therapy for refractory inflammatory bowel disease
โœ S. Palaniappan; A. C. Ford; D. Greer; S. M. Everett; D. M. Chalmers; A. T. R. Ax ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB

Background: Mycophenolate mofetil (MMF) is an immunomodulatory drug, and its use in inflammatory bowel disease has previously been reported. The aim of this study was to review the Leeds Colitis Clinic experience of the safety and efficacy of MMF in treating patients with refractory Crohn's disease

Mycophenolate mofetil for remission main
Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis
โœ Langford, Carol A. ;Talar-Williams, Cheryl ;Sneller, Michael C. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 71 KB ๐Ÿ‘ 2 views

## Objective: To examine the safety of mycophenolate mofetil (mmf) for remission maintenance in patients with wegener's granulomatosis (wg) who had been treated with daily cyclophosphamide (cyc) and glucocorticoids to induce remission. ## Methods: Fourteen patients were treated for active wg usin